Access to affordable cancer medication shouldn’t depend on where you live – Association of European Cancer Leagues
Association of European Cancer Leagues (ECL) shared a post on LinkedIn:
“Access to affordable cancer medication shouldn’t depend on where you live. Sadly, it often does.
Treating cancer is impossible without access to quality medication and care. However, novel medicines can be extremely expensive, leaving some countries unable to afford them.
This has created major inequalities across Europe. In countries with comparatively low purchasing power or lower GDP, like Romania or the Baltic states, cancer patients are faced with limited access to innovative medication.
No single country can confront this challenge on its own. This week, EU health ministers discussed two important topics to tackle this issue:
A position paper, drafted by 7 EU member states, on voluntary joint procurement to help achieve lower prices and make small markets attractive for pharma industry.
Progress made by the EU Council on the reform of the EU’s pharmaceutical legislation – a historical opportunity to make Europe’s pharmaceutical system more patient-centered.
Read more about the EU Council meeting.
Curious about our work on access to medicines? Visit our website.”
More posts featuring Association of European Cancer Leagues.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023